Artelo Biosciences
ARTL · NASDAQ
$2.62−$0.04 (−1.50%)TodayMarket closed ·
Prev close $2.66
EPS: actual vs estimate
Beat the estimate in 3 of the last 8 quarters, by 45.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $0.00 | -$0.89 | +0.0% |
| Q4 FY25 | -$43.24 | -$1.08 | +97.5% |
| Q3 FY25 | -$22.58 | -$107.19 | −374.7% |
| Q2 FY25 | -$115.39 | -$151.47 | −31.3% |
| Q1 FY25 | -$21.48 | -$116.64 | −443.0% |
| Q4 FY24 | -$72.16 | -$189.54 | −162.7% |
| Q3 FY24 | -$76.56 | -$56.70 | +25.9% |
| Q2 FY24 | -$139.90 | -$121.50 | +13.2% |
Earnings calls
- Special Call - Artelo Biosciences, Inc.
- Special Call - Artelo Biosciences, Inc.
- Special Call - Artelo Biosciences, Inc.
- ARTL - Earnings call Q3 2021
- ARTL - Earnings call Q1 2021
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.